Levocamed

Levocabastine Hydrochloride, the active ingredient in Levocamed, is an antihistamine (H1 receptor antagonist) presented as a nasal spray for nasal use. It treats allergic rhinitis and related nasal allergy symptoms in adults and children. GNH USA supplies Levocamed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levocamed is an antihistamine indicated for conditions affecting the nasal passages and allergic responses. - Allergic rhinitis: reduces nasal congestion, itching, and sneezing. - Seasonal allergic rhinitis: alleviates symptoms triggered by pollen or seasonal allergens. - Perennial allergic rhinitis: provides relief from year‑round allergen‑induced nasal irritation.

Levocamed may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation or burning sensation. - Sneezing shortly after administration. - Headache. - Dry mouth. - Unpleasant taste. - Transient epistaxis (nosebleed).

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with swelling, rash, or difficulty breathing. - Persistent nasal bleeding. - Vision changes. - Severe headache or facial pain. - Unexplained dizziness or fainting.

Before using Levocamed, consider the following precautions. - Pregnancy: consult a healthcare professional; safety data are limited. - Breastfeeding: discuss potential exposure with a physician. - Children: use only as directed by a pediatrician. - Pre‑existing nasal conditions: inform the prescriber of chronic sinusitis or nasal polyps. - Concomitant eye or ear drops: avoid simultaneous administration to reduce irritation. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Levocamed may interact with certain medications or substances.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): increased risk of hypertensive reactions. - Other antihistamines: additive sedation or anticholinergic effects.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance drowsiness. - Nasal decongestants: potential for increased nasal irritation. - CYP450 substrates: monitor for altered metabolism, though interaction risk is low.